Found: 69
Select item for more details and to access through your institution.
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
CGO: utilizing and integrating gene expression microarray data in clinical research and data management.
- Published in:
- Bioinformatics, 2002, v. 18, n. 2, p. 327, doi. 10.1093/bioinformatics/18.2.327
- By:
- Publication type:
- Article
Role of NEK2A in Human Cancer and Its Therapeutic Potentials.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/862461
- By:
- Publication type:
- Article
Nek2 Is a Novel Regulator of B Cell Development and Immunological Response.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/621082
- By:
- Publication type:
- Article
Inhibition of Nek2 by Small Molecules Affects Proteasome Activity.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/273180
- By:
- Publication type:
- Article
Macrophages: A communication network linking Porphyromonas gingivalis infection and associated systemic diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.952040
- By:
- Publication type:
- Article
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 1, p. 14, doi. 10.1002/ijc.20408
- By:
- Publication type:
- Article
Ferroportin downregulation promotes cell proliferation by modulating the Nrf2–miR-17-5p axis in multiple myeloma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 9, p. N.PAG, doi. 10.1038/s41419-019-1854-0
- By:
- Publication type:
- Article
Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 230, doi. 10.1111/ejh.13541
- By:
- Publication type:
- Article
Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model.
- Published in:
- FASEB Journal, 2023, v. 37, n. 7, p. 1, doi. 10.1096/fj.202201673RR
- By:
- Publication type:
- Article
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3621, doi. 10.3390/ijms19113621
- By:
- Publication type:
- Article
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.
- Published in:
- BMC Genomics, 2007, v. 8, p. 1, doi. 10.1186/1471-2164-8-302
- By:
- Publication type:
- Article
A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 1998, v. 23, n. 1, p. 21, doi. 10.1002/(SICI)1098-2264(199809)23:1<21::AID-GCC4>3.0.CO;2-8
- By:
- Publication type:
- Article
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
- Published in:
- Oncogene, 2005, v. 24, n. 46, p. 6936, doi. 10.1038/sj.onc.1208844
- By:
- Publication type:
- Article
CD24 Is a Phenotypic Marker and a Potential Therapeutic Target for Multiple Myeloma Tumor-Initiating Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e84, doi. 10.1016/j.clml.2019.09.135
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01380-0
- By:
- Publication type:
- Article
Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray.
- Published in:
- Modern Pathology, 2004, v. 17, n. 10, p. 1217, doi. 10.1038/modpathol.3800169
- By:
- Publication type:
- Article
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01024-8
- By:
- Publication type:
- Article
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
Extracellular vesicle expansion of PMIS‐miR‐210 expression inhibits colorectal tumour growth via apoptosis and an XIST/NME1 regulatory mechanism.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 9, p. 1, doi. 10.1002/ctm2.1037
- By:
- Publication type:
- Article
WDR26 and MTF2 are therapeutic targets in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01217-9
- By:
- Publication type:
- Article
NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 4, p. 763, doi. 10.1002/1878-0261.12641
- By:
- Publication type:
- Article
Cell lines of hyperdiploid myeloma, are we there yet? – response to Chng & Fonseca.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 6, p. 802, doi. 10.1111/j.1365-2141.2007.06742.x
- By:
- Publication type:
- Article
Fibroblast activation protein ( FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 1, p. 83, doi. 10.1111/j.1365-2141.2006.05976.x
- By:
- Publication type:
- Article
CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 1, p. 36, doi. 10.1046/j.1365-2141.2003.04260.x
- By:
- Publication type:
- Article
Variability of definition of high‐risk multiple myeloma across phase III clinical trials.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 454, doi. 10.1002/jha2.675
- By:
- Publication type:
- Article
Catalyst-Free One-Pot Synthesis of Densely Substituted Pyrazole-Pyrazines as Anti-Colorectal Cancer Agents.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66137-z
- By:
- Publication type:
- Article
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20524-2
- By:
- Publication type:
- Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
- By:
- Publication type:
- Article
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 5, p. 354, doi. 10.1111/j.1600-0609.2009.01225.x
- By:
- Publication type:
- Article
Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109758
- By:
- Publication type:
- Article
Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse <i>In Vitro</i> Model of Multiple Myeloma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077608
- By:
- Publication type:
- Article
Down-Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by Bortezomib Sensitizes Jurkat Leukemia T Cells against Glucocorticoid-Induced Apoptosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067067
- By:
- Publication type:
- Article
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 16, p. 2491, doi. 10.1002/cncr.34895
- By:
- Publication type:
- Article
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/ Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 228, doi. 10.1016/j.clml.2011.03.006
- By:
- Publication type:
- Article
HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Chimeric antigen receptor T cell therapies for multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0823-5
- By:
- Publication type:
- Article
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0005-2
- By:
- Publication type:
- Article
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0005-2
- By:
- Publication type:
- Article
Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0167323
- By:
- Publication type:
- Article
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.
- Published in:
- Cell Division, 2006, v. 1, p. 23, doi. 10.1186/1747-1028-1-23
- By:
- Publication type:
- Article
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
- Published in:
- Immunologic Research, 2014, v. 59, n. 1-3, p. 188, doi. 10.1007/s12026-014-8528-x
- By:
- Publication type:
- Article
GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-020-01564-2
- By:
- Publication type:
- Article